Objective assessment of cancer genes for drug discovery (Q57001160)

Europe PubMed Central

title

Objective assessment of cancer genes for drug discovery (English)

0 references

1 reference

Bissan Al-Lazikani

5

0 references

Paul Workman

4

object named as

Paul Workman

0 references

author name string

Mishal N. Patel

1

0 references

Mark D. Halling-Brown

2

0 references

Joseph E. Tym

Nature Reviews Drug Discovery

3

0 references

publication date

January 2013

0 references

published in

0 references

volume

12

0 references

issue

1

0 references

page(s)

35-50

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/nrd3913

0 references

cites work

Global cancer statistics

1 reference

Advances in understanding cancer genomes through second-generation sequencing

31 March 2020

1 reference

Principles for the post-GWAS functional characterization of cancer risk loci

31 March 2020

1 reference

The grand challenge to decipher the cancer proteome.

31 March 2020

1 reference

Functional viability profiles of breast cancer

31 March 2020

1 reference

An integrated platform of genomic assays reveals small-molecule bioactivities

31 March 2020

1 reference

Probing the probes: fitness factors for small molecule tools

31 March 2020

1 reference

Making sense of cancer genomic data

31 March 2020

1 reference

Circumventing cancer drug resistance in the era of personalized medicine

31 March 2020

1 reference

Clonal evolution in cancer

31 March 2020

1 reference

Exploring the genomes of cancer cells: progress and promise

31 March 2020

1 reference

Combinatorial drug therapy for cancer in the post-genomic era.

31 March 2020

1 reference

Abiraterone and increased survival in metastatic prostate cancer

31 March 2020

1 reference

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

31 March 2020

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

31 March 2020

1 reference

The productivity crisis in pharmaceutical R&D.

31 March 2020

1 reference

Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeutics

31 March 2020

1 reference

Fragment screening to predict druggability (ligandability) and lead discovery success.

31 March 2020

1 reference

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

31 March 2020

1 reference

The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members

31 March 2020

1 reference

International network of cancer genome projects

31 March 2020

1 reference

Utilizing RNA interference to enhance cancer drug discovery

31 March 2020

1 reference

Genomic-scale prioritization of drug targets: the TDR Targets database

31 March 2020

1 reference

ChEMBL: a large-scale bioactivity database for drug discovery

31 March 2020

1 reference

canSAR: an integrated cancer public translational research and drug discovery resource

31 March 2020

1 reference

Drug development: Raise standards for preclinical cancer research

31 March 2020

1 reference

Believe it or not: how much can we rely on published data on potential drug targets?

31 March 2020

1 reference

A census of human cancer genes

31 March 2020

1 reference

How many drug targets are there?

31 March 2020

1 reference

Transcription factors as targets for cancer therapy

31 March 2020

1 reference

Direct inhibition of the NOTCH transcription factor complex

31 March 2020

1 reference

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

31 March 2020

1 reference

The STATs of cancer--new molecular targets come of age

31 March 2020

1 reference

ETS transcription factors and their emerging roles in human cancer

31 March 2020

1 reference

31 March 2020

Outsmarting a mastermind

1 reference

The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo.

31 March 2020

1 reference

The genome of the blood fluke Schistosoma mansoni

31 March 2020

1 reference

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease

31 March 2020

1 reference

Use of genome-wide association studies for drug repositioning

31 March 2020

1 reference

PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway

31 March 2020

1 reference

Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1.

31 March 2020

1 reference

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

31 March 2020

1 reference

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

31 March 2020

1 reference

Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene

31 March 2020

1 reference

Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.

31 March 2020

1 reference

A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism

31 March 2020

1 reference

A small molecule inverse agonist for the human thyroid-stimulating hormone receptor

31 March 2020

1 reference

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

31 March 2020

1 reference

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

31 March 2020

1 reference

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

31 March 2020

1 reference

A novel retinoblastoma therapy from genomic and epigenetic analyses

31 March 2020

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

31 March 2020

1 reference

Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP.

31 March 2020

1 reference

Structural biology and drug discovery of difficult targets: the limits of ligandability

31 March 2020

1 reference

New approaches to molecular cancer therapeutics

31 March 2020

1 reference

The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis

31 March 2020

1 reference

A tumor suppressor and oncogene: the WT1 story.

31 March 2020

1 reference

E1A: tumor suppressor or oncogene? Preclinical and clinical investigations of E1A gene therapy

31 March 2020

1 reference

Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA.

31 March 2020

1 reference

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

31 March 2020

1 reference

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

31 March 2020

1 reference

Virchow 2011 or how to ID(H) human glioblastoma.

31 March 2020

1 reference

PubChem: Integrated Platform of Small Molecules and Biological Activities

31 March 2020

1 reference

Cloning, expression, and characterization of a soluble calcium-activated nucleotidase, a human enzyme belonging to a new family of extracellular nucleotidases

31 March 2020

1 reference

Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer

31 March 2020

1 reference

The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro.

31 March 2020

1 reference

Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines

31 March 2020

1 reference

The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways.

31 March 2020

1 reference

Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas

31 March 2020

1 reference

Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis

31 March 2020

1 reference

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits

31 March 2020

1 reference

Selective inhibition of BET bromodomains

31 March 2020

1 reference

31 March 2020

The Protein Data Bank

1 reference

New method for fast and accurate binding-site identification and analysis

31 March 2020

1 reference

Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck

31 March 2020

1 reference

Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites

31 March 2020

1 reference

The Binding Database: data management and interface design

31 March 2020

1 reference

The NCI60 human tumour cell line anticancer drug screen

31 March 2020

1 reference

Basic local alignment search tool

31 March 2020

1 reference

The scientific impact of the Structural Genomics Consortium: a protein family and ligand-centered approach to medically-relevant human proteins

31 March 2020

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23274470

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23274470